Dr. Mukesh Prakash Sharoha, MD

Dr. Sharoha practices at Nassau University Medical Center in East Meadow, New York, part of NuHealth.

Dr. Sharoha's NPI, 1275614125, was assigned on October 18, 2006. Dr. Sharoha holds New York license 237417.

Dr. Sharoha's primary practice is Nassau University Medical Center, at 2201 Hempstead Turnpike, East Meadow, NY 11554 in Nassau County. The practice phone is (516) 572-0123.

Dr. Sharoha's primary practice is Nassau University Medical Center in East Meadow, New York, part of NuHealth. The medical group on file is Nassau University Medical Center (NUMC), Department of Psychiatry and Behavioral Sciences. Dmand AI also links Dr. Sharoha to 1 more hospital, named with a free account. Dr. Sharoha's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharoha practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Sharoha's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Sharoha is licensed in New York.

CMS data shows 269 Medicare services from Dr. Sharoha across 6 procedure codes in 2024, for 207 Medicare patients. Medicare paid $17,204 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 207 Medicare patients who saw Dr. Sharoha in 2024. The largest group is under 65, with 110 patients. 73% of them have mood disorders, and 73% have schizophrenia and other psychoses. 70% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sharoha's median patient age at 29, with 42% women.

In 2024, Dr. Sharoha wrote 1,929 Medicare Part D claims for 68 patients. 91% of them were for generic drugs. CMS names the drug for 1,817 of them, across 42 drugs with 11 or more claims each, at $396,023 in total drug cost. In 2023, CMS named 1,846 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Sharoha for performance year 2024, reported as part of a group. Dr. Sharoha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Sharoha from 1 drug or device company from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $138.